Figure 2.
Scatter diagram analyses of the relationships between decreased levels of C-reactive protein (CRP), fibrinogen (Fg), and D-dimer (DD); and decreased levels of low-density lipoprotein cholesterol (LDL-C) and total cholesterol (TC) in the study group after 4 weeks of treatment with atorvastatin.
There were no significant correlations between decreased levels of markers of inflammation and thrombogenesis, and decreased levels of markers of hyperlipidemia (A–F; rank correlation test).